Arcus Biosciences, Inc.
RCUS
$8.62
$0.111.29%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 997.00M | 978.00M | 1.09B | 969.00M | 995.00M |
| Total Receivables | 21.00M | 25.00M | 21.00M | 33.00M | 40.00M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 13.00M | 13.00M | 17.00M | 20.00M | 29.00M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.03B | 1.02B | 1.13B | 1.02B | 1.06B |
|
|
|||||
| Total Current Assets | 1.03B | 1.02B | 1.13B | 1.02B | 1.06B |
| Net Property, Plant & Equipment | 46.00M | 112.00M | 48.00M | 49.00M | 51.00M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 71.00M | 8.00M | 75.00M | 75.00M | 78.00M |
| Total Assets | 1.16B | 1.15B | 1.25B | 1.19B | 1.29B |
|
|
|||||
| Total Accounts Payable | 22.00M | 18.00M | 13.00M | 15.00M | 16.00M |
| Total Accrued Expenses | 69.00M | 96.00M | 84.00M | 58.00M | 52.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.00M | 12.00M | 11.00M | 11.00M | 11.00M |
| Total Finance Division Other Current Liabilities | 89.00M | 100.00M | 107.00M | 115.00M | 125.00M |
| Total Other Current Liabilities | 89.00M | 100.00M | 107.00M | 115.00M | 125.00M |
| Total Current Liabilities | 192.00M | 226.00M | 215.00M | 199.00M | 204.00M |
|
|
|||||
| Total Current Liabilities | 192.00M | 226.00M | 215.00M | 199.00M | 204.00M |
| Long-Term Debt | 69.00M | 48.00M | 68.00M | -- | 20.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 99.00M | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 364.00M | 292.00M | 404.00M | 352.00M | 362.00M |
| Total Liabilities | 625.00M | 665.00M | 687.00M | 551.00M | 586.00M |
|
|
|||||
| Common Stock & APIC | 1.78B | 1.62B | 1.60B | 1.58B | 1.56B |
| Retained Earnings | -1.24B | -1.13B | -1.04B | -946.00M | -853.00M |
| Treasury Stock & Other | -- | -- | 1.00M | -1.00M | -1.00M |
| Total Common Equity | 531.00M | 485.00M | 565.00M | 635.00M | 707.00M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 531.00M | 485.00M | 565.00M | 635.00M | 707.00M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 531.00M | 485.00M | 565.00M | 635.00M | 707.00M |
|
|
|||||